“Sur les vaccins, plus on ira vite, plus on empêchera de nouveaux variants de surgir”

Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.

Read the full article published by Nature with a contribution […]

During the interview given to RTBF Auvio, our co-director, Michel Goldman stressed the importance of the collective intelligence and collaborative research as keys in the fight against the pandemic. […]

Our co-director, Michel Goldman has given an interview to L’Echo where he discusses COVID-19 vaccines launch in Belgium. Read the full article to find out about the next steps […]

Nous avons le plaisir de vous convier au webinaire organisé par le Collège de France et le Collège Belgique, le 15 janvier 2021 de 9h à 12h. Accès libre […]

As the EU considers establishing an Agency comparable to the U.S. Biomedical Advanced Research and Development Authority (BARDA), our colleagues outlines a set of recommendations during #A2MDialogues organised by […]

ADVANCE is a 30-month EU training project, supported by Erasmus Plus with the objective to develop a 3-stage blended learning programme to support early-career biomedical scientists in developing currently […]

The advent of large data sets and sophisticated empirical analyses have reopened the scholarly debate on how to improve the traditional models of judicial behavior with a more data-driven […]

Jeudi 10 décembre à 14h

Le système immunitaire face au virus SARS-CoV-2

Professeur Michel Goldman

Titulaire du cours […]

Our co-director, Mathias.Dewatripont was interviewed by RTBF and Le Soir for their joint programme Le Grand Oral, following the reopening of certain facilities due to the relaxation of the […]